As hospitals reduced their spending on oncology treatments due to the increasing availability of biosimilars, the reimbursements they received from insurers did not drop at the same rate—allowing h | ...

The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic ...

The U.S. Food and Drug Administration (FDA)’s March 2026 update to its biosimilar Q&A guidance arrives at a critical inflection point for ...

The Surprise Winner And What It Means For The Novo-Lilly Rivalry Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade) Pfizer: Obesity Hype And Vaccine Policy Shocks Roche stock falls ...

Amneal Pharmaceuticals (NASDAQ:AMRX) used a recent investor presentation to highlight momentum coming out of fiscal 2025 and ...

The FDA is doubling down on its goal to increase biosimilar drug availability in the U.S. | The FDA's newest draft guidance reinforces its previous commitment to streamlining biosimilar drug ...

Sandoz has not minced words about the massive, yet largely untapped opportunity biosimilar makers are presented with as dozens of branded medicines inch toward the patent cliff in the next decade.& | ...

The updated guidance allows originators to cite existing comparative data, not exclusively from the United States, for clinical pharmacokinetic testing.

Adoption rose dramatically as markup margins increased with cost-reimbursement mismatch ...

LAS VEGAS—Optum Rx is planning to add up to three biosimilar drugs to its formulary to compete directly with AbbVie's Humira, which accounts for massive pharmacy spend each year. Optum Rx, the ...

Biosimilars play a critical role in lowering the price of prescription drugs, with the potential to save $180 billion over the next five years if the United States can increase its use over biologic ...

January 31 is set to mark the start of a watershed year for the biosimilars industry with the release of Amjevita, the first biosimilar for Humira, the world’s best-selling drug. Several more Humira ...